NIH Data Sharing Policy

NIH Data Sharing Policy
Name	NIH Data Sharing Policy
Jurisdiction	United States
Agency	National Institutes of Health
Status	Active

NIH Data Sharing Policy

The National Institutes of Health policy on data sharing articulates expectations for the stewardship, accessibility, and reuse of research data funded by the National Institutes of Health. It aims to accelerate scientific discovery, foster collaboration across institutions such as Harvard University, Johns Hopkins University, and Stanford University, and align with international norms exemplified by European Commission and World Health Organization initiatives. The policy interacts with statutes and frameworks including the Health Insurance Portability and Accountability Act of 1996 and the Federal Information Security Modernization Act of 2014 while influencing repositories like GenBank and dbGaP.

Background and objectives

The policy emerged from calls for transparency voiced in forums including the Berkman Klein Center and recommendations by panels such as the National Academies of Sciences, Engineering, and Medicine. It responds to high-profile data-sharing debates surrounding studies at institutions like Massachusetts Institute of Technology and controversies involving datasets tied to researchers at University of California, Berkeley and Yale University. Objectives include increasing reproducibility, promoting secondary analyses at centers such as Mayo Clinic and Cleveland Clinic, and enabling multi-center projects supported by programs like the Human Genome Project and consortia modeled on the Human Cell Atlas.

Scope and applicability

The policy applies to extramural awards and intramural programs administered by the National Institutes of Health and affects investigators at organizations including University of Oxford, Karolinska Institute, Sanger Institute, and smaller grantees such as Howard University and community-based partners. It covers data generated under grant mechanisms like the R01 (United States) and cooperative agreements similar to those used by the National Cancer Institute. Exclusions and special provisions can arise for classified work associated with agencies like the Department of Defense or when statutes such as the Privacy Act of 1974 impose constraints.

Data management and sharing requirements

Awardees must submit plans analogous to those required by funders like the National Science Foundation and the Wellcome Trust. Plans address data types deposited in repositories such as ClinicalTrials.gov, Sequence Read Archive, and discipline-specific archives used by the European Bioinformatics Institute and the Protein Data Bank. Elements include metadata standards promoted by initiatives like the FAIR principles (aligned with practices at European Molecular Biology Laboratory), data dictionaries developed by consortia such as the Alzheimer's Disease Neuroimaging Initiative, and persistent identifiers modeled on the Digital Object Identifier system. Budgets may allocate funds for data curation at core facilities like those at University of California, San Francisco and for infrastructure interoperable with National Center for Biotechnology Information services.

Implementation and compliance

Implementation draws on administrative mechanisms used by agencies such as the National Science Foundation and procedural precedents from National Institutes of Health policy rollouts including prior guidance on public access to publications. Compliance monitoring leverages progress reports similar to those required by the Office of Management and Budget and audit practices familiar to Government Accountability Office. Noncompliance may trigger corrective actions paralleling those used by the Department of Health and Human Services, and program officers at institutes such as the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute advise awardees on remediation. Training initiatives echo curricula from institutions like University of Michigan and Columbia University to build capacity for data stewardship.

Privacy, security, and ethical considerations

Protections reflect requirements under the Health Insurance Portability and Accountability Act of 1996 and guidance from bodies such as the Office for Human Research Protections and the Presidential Commission for the Study of Bioethical Issues. De-identification practices align with methodologies used in large cohort studies at Framingham Heart Study and biobanks like the UK Biobank. Security controls reference standards promulgated by the National Institute of Standards and Technology and parallel models from the European Union Agency for Cybersecurity. Ethical review by institutional boards, including models maintained by Massachusetts General Hospital and Brigham and Women's Hospital, governs consent and secondary use, while special considerations address vulnerable populations studied in projects at Centers for Disease Control and Prevention.

Impact and reception

The policy influenced data-sharing behavior across research ecosystems involving stakeholders such as Nature (journal), Science (journal), and repositories like Figshare. Advocates from organizations including the Open Science Framework and critics from some academic coalitions debated trade-offs between openness and proprietary interests seen in partnerships with entities like Pfizer and GlaxoSmithKline. Empirical evaluations cite increased deposition rates comparable to trends reported by the European Research Council and measurable reuse examples in projects linked to Human Microbiome Project. Ongoing discourse involves legislative attention from committees in the United States Congress and international dialogue at venues like the World Economic Forum.

Category:United States federal policy Category:Research data management